199 related articles for article (PubMed ID: 22703382)
21. Effects of sex and the common ADRB1 389 genetic polymorphism on the hemodynamic response to dobutamine.
Yogev D; Basheer M; Blotnick S; Caraco Y; Muszkat M
Pharmacogenet Genomics; 2015 Nov; 25(11):555-63. PubMed ID: 26313487
[TBL] [Abstract][Full Text] [Related]
22. Association of CYP2D6 and ADRB1 genes with hypotensive and antichronotropic action of betaxolol in patients with arterial hypertension.
Zateyshchikov DA; Minushkina LO; Brovkin AN; Savel'eva EG; Zateyshchikova AA; Manchaeva BB; Nikitin AG; Sidorenko BA; Nosikov VV
Fundam Clin Pharmacol; 2007 Aug; 21(4):437-43. PubMed ID: 17635183
[TBL] [Abstract][Full Text] [Related]
23. Effects of polymorphisms in beta1-adrenoceptor and alpha-subunit of G protein on heart rate and blood pressure during exercise test. The Finnish Cardiovascular Study.
Nieminen T; Lehtimäki T; Laiho J; Rontu R; Niemelä K; Kööbi T; Lehtinen R; Viik J; Turjanmaa V; Kähönen M
J Appl Physiol (1985); 2006 Feb; 100(2):507-11. PubMed ID: 16210433
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the effects on renin release of beta adrenergic antagonists with differing properties.
Weber MA; Stokes GS; Gain JM
J Clin Invest; 1974 Dec; 54(6):1413-9. PubMed ID: 4154950
[TBL] [Abstract][Full Text] [Related]
25. Sympathetic cardiac influence and arterial blood pressure instability.
Formes KJ; Wray DW; O-Yurvati AH; Weiss MS; Shi X
Auton Neurosci; 2005 Mar; 118(1-2):116-24. PubMed ID: 15795185
[TBL] [Abstract][Full Text] [Related]
26. Beta-2-adrenergic receptor polymorphisms and changes in lipids induced by metoprolol.
Isaza CA; Henao J; Sánchez JC; Porras GL; Cardona J; Bedoya G
Pharmacology; 2007; 80(4):279-85. PubMed ID: 17671401
[TBL] [Abstract][Full Text] [Related]
27. [Beta1-adrenergic receptor (Arg389Gly) polymorphism and response to bisoprolol in patients with chronic heart failure].
Yu WP; Lou M; Deng B; Song HM; Wang HB
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Sep; 34(9):776-80. PubMed ID: 17217681
[TBL] [Abstract][Full Text] [Related]
28. Impact of the β1-adrenoceptor Arg389Gly polymorphism on heart-rate responses to bisoprolol and carvedilol in heart-failure patients.
Rau T; Düngen HD; Edelmann F; Waagstein F; Lainščak M; Dimković S; Apostolović S; Nešković AN; Haverkamp W; Gelbrich G; Eschenhagen T
Clin Pharmacol Ther; 2012 Jul; 92(1):21-8. PubMed ID: 22617224
[TBL] [Abstract][Full Text] [Related]
29. Plasma renin activity, active and inactive renin concentrations, and their responses to beta 1-adrenoceptor blockade with metoprolol in hyperthyroidism.
Baba T; Murabayashi S; Aoyagi K; Kitaoka M; Nakazono M; Ishizaki T; Kurimoto F; Sakurai H; Takebe K
Horm Metab Res; 1986 Sep; 18(9):630-4. PubMed ID: 3023226
[TBL] [Abstract][Full Text] [Related]
30. [The effect of a submaximal physical load on the beta 2-adrenoreceptor-dependent adenylate cyclase system of the lymphocytes in hypertension].
Aripova NA; Parfenova EV; Bosykh EG; Naumann E; Krasnikova TL
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1989; 12(2):46-54. PubMed ID: 2557857
[TBL] [Abstract][Full Text] [Related]
31. Influence of phenotype and pharmacokinetics on beta-blocker drug target pharmacogenetics.
Beitelshees AL; Zineh I; Yarandi HN; Pauly DF; Johnson JA
Pharmacogenomics J; 2006; 6(3):174-8. PubMed ID: 16402084
[TBL] [Abstract][Full Text] [Related]
32. Polymorphisms of adrenoceptors are not associated with an increased risk of adverse event in heart failure: a MERIT-HF substudy.
Savva J; Maqbool A; White HL; Galloway SL; Yuldasheva NY; Ball SG; West RM; De Boer RA; Van Veldhuisen DJ; Balmforth AJ;
J Card Fail; 2009 Jun; 15(5):435-41. PubMed ID: 19477404
[TBL] [Abstract][Full Text] [Related]
33. Functional effects of β₁-adrenoceptor polymorphisms on the hemodynamic response to dobutamine with and without β-blocker administration.
Kindermann M; Seeland U; Ruhnke P; Böhm M; Maack C
Clin Res Cardiol; 2011 Feb; 100(2):129-37. PubMed ID: 20821015
[TBL] [Abstract][Full Text] [Related]
34. Human heart beta-adrenoceptors: beta1-adrenoceptor diversification through 'affinity states' and polymorphism.
Molenaar P; Chen L; Semmler AB; Parsonage WA; Kaumann AJ
Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1020-8. PubMed ID: 17714089
[TBL] [Abstract][Full Text] [Related]
35. Impact of β(1)- and β(2)-adrenergic receptor gene single nucleotide polymorphisms on heart rate response to metoprolol prior to coronary computed tomographic angiography.
Cotarlan V; Brofferio A; Gerhard GS; Chu X; Shirani J
Am J Cardiol; 2013 Mar; 111(5):661-6. PubMed ID: 23261005
[TBL] [Abstract][Full Text] [Related]
36. Differential effects of metoprolol and atenolol to neuropeptide Y blockade in coronary artery disease.
Gullestad L; Pernow J; Bjurö T; Aaberge L; Skårdal R; Kjekshus E; Høglund L; Mellgård AJ; Wahlquist I; Ablad B
Scand Cardiovasc J; 2012 Feb; 46(1):23-31. PubMed ID: 22017530
[TBL] [Abstract][Full Text] [Related]
37. Impact of the β-1 adrenergic receptor polymorphism on tolerability and efficacy of bisoprolol therapy in Korean heart failure patients: association between β adrenergic receptor polymorphism and bisoprolol therapy in heart failure (ABBA) study.
Lee HY; Chung WJ; Jeon HK; Seo HS; Choi DJ; Jeon ES; Kim JJ; Shin JH; Kang SM; Lim SC; Baek SH
Korean J Intern Med; 2016 Mar; 31(2):277-87. PubMed ID: 26879662
[TBL] [Abstract][Full Text] [Related]
38. β-Adrenergic receptor gene polymorphism is a genetic risk factor for cardiovascular disease: a cohort study with hypertensive patients.
Iwamoto Y; Ohishi M; Yuan M; Tatara Y; Kato N; Takeya Y; Onishi M; Maekawa Y; Kamide K; Rakugi H
Hypertens Res; 2011 May; 34(5):573-7. PubMed ID: 21289629
[TBL] [Abstract][Full Text] [Related]
39. Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma.
Bleecker ER; Yancey SW; Baitinger LA; Edwards LD; Klotsman M; Anderson WH; Dorinsky PM
J Allergy Clin Immunol; 2006 Oct; 118(4):809-16. PubMed ID: 17030231
[TBL] [Abstract][Full Text] [Related]
40. The effect of AST-120 on the single-dose pharmacokinetics of metoprolol extended-release tablets in healthy subjects.
Inoue S; Shimizu M; Arita K; Akimoto K
Drug Metabol Drug Interact; 2014; 29(2):115-21. PubMed ID: 24643911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
